10.5281/zenodo.6370579
https://zenodo.org/records/6370579
oai:zenodo.org:6370579
Alshafie, Walaa
Walaa
Alshafie
0000-0001-7999-1297
Montreal Neurological Institute
Fotouhi, Maryam
Maryam
Fotouhi
0000-0001-8937-4719
Montreal Neurological Institute
Ayoubi, Riham
Riham
Ayoubi
0000-0001-6633-655X
Montreal Neurological Institute
McPherson, Peter S.
Peter S.
McPherson
0000-0001-7806-5662
Montreal Neurological Institute
Laflamme, Carl
Carl
Laflamme
0000-0001-5906-025X
Montreal Neurological Institute
Antibody Characterization Report for Progranulin
Zenodo
2022
Progranulin
PGRN
GRN
antibody validation
antibody characterization
ALS-RAP
amyotrophic lateral sclerosis
P28799
YCharOS
2022-03-19
eng
10.5281/zenodo.6370578
https://zenodo.org/communities/ycharos
Creative Commons Attribution 4.0 International
Head-to-head comparison of available commercial antibodies against Progranulin by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work is supported by the ALS-Reproducible Antibody Platform (ALS-RAP), a public-private partnership established by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.